
Ask a doctor about a prescription for Indigokarmin Serb
Indigotinum
Pharmacotherapeutic group: diagnostic agent, ATC code: V04CH02
Indigocarmine SERB solution for injection contains the active substance indigotin (indigocarmine).
This medicine is intended for diagnostic use in adults only.
It is a dye used by the surgeon and anesthesiologist during abdominal surgery.
The product changes the color of the urine (to dark blue) within 5 to 15 minutes after injection.
This color allows for the identification of the course of the ureters (channels that carry urine from the kidneys to the bladder) and to check if they have been damaged during the procedure.
Before starting treatment with Indigocarmine SERB, discuss it with your doctor or pharmacist:
Tell your doctor or pharmacist about all the medicines the patient is taking, has recently taken, or might take.
As a precaution, it is recommended not to use this product during pregnancy or breastfeeding.
If the patient is pregnant, breastfeeding, thinks she may be pregnant, or plans to have a baby, she should consult her doctor or pharmacist before using this medicine.
The medicine will be administered by a qualified healthcare professional in a slow intravenous injection.
The doctor will determine the dose the patient will receive and will monitor the injection of this medicine. The usual dose is 1 ampoule of 5 mL and, if necessary, this dose may be repeated once.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Very common side effects may include:
If you experience any side effects, including those not listed in this leaflet, tell your doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
PL-02 222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep the medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the carton after "EXP". The expiry date refers to the last day of the month.
Before opening: no special precautions for storage.
After opening the ampoule: use immediately.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
This medicine is available as a solution for injection in ampoules. One pack contains 10 ampoules.
SERB SA
Avenue Louise 480
1050 Brussels
Belgium
phone: +48 22 307 03 61
SERB
40 Avenue George V
75008 Paris
France
SERB SA
Avenue Louise 480
1050 Brussels
Belgium
Belgium
Carmin d’indigo Serb
Indigokarmijn Serb
Indigokarmin Serb
Denmark
Carmyne
Finland
Carmyne
France
Carmyne
Netherlands
Indigokarmijn Serb
Luxembourg
Carmin d’indigo Serb
Germany
Indigokarmin Serb
Norway
Carmyne
Poland
Indygokarmin SERB
Sweden
Carmyne
United Kingdom
(Northern Ireland)
Indigo carmine
------------------------------------------------------------------------------------------------------------------------
Due to the dark blue color of Indigocarmine SERB, during intravenous administration, filtration is necessary (e.g., 0.45 μm filter with a filtration area of at least 2.8 cm² or 0.2 μm filter with a filtration area of 4.3 cm², consisting of a hydrophilic polyethersulfone membrane).
This medicine should be administered intravenously. The initial recommended dose is 1 ampoule of 5 mL in slow intravenous injection.
If necessary, a second ampoule can be administered 20 to 30 minutes after the first injection.
In children:
The efficacy and safety of Indigocarmine SERB in children have not been established.
In patients with renal impairment:
Indigocarmine SERB is not recommended in patients with a glomerular filtration rate (GFR) <30 ml min.
In elderly patients:
Dose adjustment is not necessary.
In patients with hepatic impairment:
Elimination of Indigocarmine SERB is mainly through the kidneys. Although there are no data on patients with hepatic impairment, no dose adjustment is required.
Before opening: no special precautions for storage.
After opening the ampoule: use immediately.
The solution can only be administered if the ampoule is not damaged.
Unused solution should be discarded.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for Indigokarmin Serb – subject to medical assessment and local rules.